PUBLISHER: iData Research Inc. | PRODUCT CODE: 1509744
PUBLISHER: iData Research Inc. | PRODUCT CODE: 1509744
CAGR of 5.7%, reaching nearly $6.5 billion by the end of the forecast period.
The comprehensive report on the U.S. market for urological devices covers various segments, including urinary incontinence devices, stone management devices, benign prostate hyperplasia (BPH) treatment devices, urological endoscopes, prostate cancer treatment devices, urodynamic equipment, nephrostomy devices, men's reproductive health devices, and urinary guidewires.
Unit Sales, Average Selling Prices, Market Value & Growth Trends
10 Year Scope
Market Drivers & Limiters for Each Segment
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors
As hospitals continue to expand their acquisitions of outpatient facilities and group purchasing organizations (GPOs) grow their influence, coupled with ongoing cuts in reimbursement rates in the urology sector, Average Selling Prices (ASPs) are likely to face ongoing pressure, potentially stifling future market growth.
Since its U.S. debut in 2013, NeoTract's UroLift(R) has seen rapid adoption among urologists for the treatment of Benign Prostatic Hyperplasia (BPH), mirroring its popularity in regions including Europe, Canada, and Australia. This minimally invasive procedure offers a quick recovery, enhancing its appeal. The 2017 acquisition of NeoTract by Teleflex has bolstered UroLift(R)'s market penetration, benefiting from Teleflex's extensive sales network. In September 2021, the launch of the UroLift Advanced Tissue Control (ATC)(R) and UroLift(R) 2 systems aimed to enhance patient safety and reduce logistical burdens, building on the original's clinical success.
While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:
Urinary Incontinence Devices Market - MedCore - The market for urinary incontinence treatments includes urinary catheters, urethral bulking agents, incontinence management devices, and urinary bags.
Stone Management Devices - MedCore - The total market for stone management devices includes ESWL capital equipment, ISWL equipment, Holmium lasers, Thulium lasers, stone fragment retrieval devices, ureteral stents, access sheaths.
BPH Treatment Devices - MedCore - The BPH treatment device market includes devices used for TURP, TUMT, TUNA, temporary prostatic stent, laser BPH, UroLift(R), Rezum(R) and iTind(R) procedures.
Urological Endoscope - MedCore - The urological endoscope market includes cystoscopes, ureteroscopes, resectoscopes and nephroscopes.
Prostate Cancer Treatment Devices - MedCore - The prostate cancer treatment device market includes brachytherapy devices, cryotherapy ablation devices, and hydrogel rectal spacers.
Urodynamic Equipment Market - MedCore - The market for urodynamic equipment includes urodynamic equipment and urodynamic consumables.
Nephrostomy Devices - MedCore - The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters and nephrostomy drainage tubes.
Men's Reproductive Health Market - MedCore - The total market for men's reproductive health treatment devices includes inflatable erectile dysfunction devices, malleable erectile dysfunction devices, vacuum assisted erectile dysfunction devices, and testicular implants.
Urinary Guidewire Market - MedCore - The market for guidewires includes all guidewires to be used in urological procedures CAGR of 5.7%, reaching nearly $6.5 billion by the end of the forecast period.
The comprehensive report on the U.S. market for urological devices covers various segments, including urinary incontinence devices, stone management devices, benign prostate hyperplasia (BPH) treatment devices, urological endoscopes, prostate cancer treatment devices, urodynamic equipment, nephrostomy devices, men's reproductive health devices, and urinary guidewires.
Unit Sales, Average Selling Prices, Market Value & Growth Trends
10 Year Scope
Market Drivers & Limiters for Each Segment
Competitive Analysis with Market Shares for Each Segment
Recent Mergers & Acquisitions
Disease Overviews and Demographic Information
Company Profiles, Product Portfolios and SWOT for Top Competitors
As hospitals continue to expand their acquisitions of outpatient facilities and group purchasing organizations (GPOs) grow their influence, coupled with ongoing cuts in reimbursement rates in the urology sector, Average Selling Prices (ASPs) are likely to face ongoing pressure, potentially stifling future market growth.
Since its U.S. debut in 2013, NeoTract's UroLift(R) has seen rapid adoption among urologists for the treatment of Benign Prostatic Hyperplasia (BPH), mirroring its popularity in regions including Europe, Canada, and Australia. This minimally invasive procedure offers a quick recovery, enhancing its appeal. The 2017 acquisition of NeoTract by Teleflex has bolstered UroLift(R)'s market penetration, benefiting from Teleflex's extensive sales network. In September 2021, the launch of the UroLift Advanced Tissue Control (ATC)(R) and UroLift(R) 2 systems aimed to enhance patient safety and reduce logistical burdens, building on the original's clinical success.
While this report suite contains all applicable market data, each of the markets are also available as stand alone MedCore reports. This allows you to get access to only the specific market segment research that you need. You can view all these included reports and segmentation here:
Urinary Incontinence Devices Market - MedCore - The market for urinary incontinence treatments includes urinary catheters, urethral bulking agents, incontinence management devices, and urinary bags.
Stone Management Devices - MedCore - The total market for stone management devices includes ESWL capital equipment, ISWL equipment, Holmium lasers, Thulium lasers, stone fragment retrieval devices, ureteral stents, access sheaths.
BPH Treatment Devices - MedCore - The BPH treatment device market includes devices used for TURP, TUMT, TUNA, temporary prostatic stent, laser BPH, UroLift(R), Rezum(R) and iTind(R) procedures.
Urological Endoscope - MedCore - The urological endoscope market includes cystoscopes, ureteroscopes, resectoscopes and nephroscopes.
Prostate Cancer Treatment Devices - MedCore - The prostate cancer treatment device market includes brachytherapy devices, cryotherapy ablation devices, and hydrogel rectal spacers.
Urodynamic Equipment Market - MedCore - The market for urodynamic equipment includes urodynamic equipment and urodynamic consumables.
Nephrostomy Devices - MedCore - The market for nephrostomy devices includes percutaneous nephrostomy sets, nephrostomy balloon catheters and nephrostomy drainage tubes.
Men's Reproductive Health Market - MedCore - The total market for men's reproductive health treatment devices includes inflatable erectile dysfunction devices, malleable erectile dysfunction devices, vacuum assisted erectile dysfunction devices, and testicular implants.
Urinary Guidewire Market - MedCore - The market for guidewires includes all guidewires to be used in urological procedures.
TABLE of CONTENTS
List of Figures
List of Charts
executive summary
U.S. Urological Device Market Overview
Competitive Analysis
Market Trends
Market Developments
Procedure Included
Procedure Codes Investigated
Markets Included
Key Report Updates
Version History
research methodology
impact of covid-19 on THE U.S. Urological Device Market
Disease overview
Product Assessment
U.S. Urological Device Market Overview
Procedure Numbers
Urinary Incontinence Device Market
Stone Management Device Market
BPH Treatment Device Market
Urological Endoscope Market
Prostate Cancer Treatment Device Market
Urodynamic Equipment Market
Nephrostomy Device Market
Men's Reproductive Health Market
Urinary Guidewire Market